Gendius Ltd

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Gendius Ltd - overview

Established

2011

Location

Cheshire, -, UK

Primary Industry

Healthcare IT

About

Gendius Ltd is a health technology company focused on developing innovative solutions for diabetes management, enhancing patient care through data analytics and personalized monitoring tools. Founded in 2011 in Cheshire, UK, Gendius Ltd specializes in health technology solutions for chronic condition management. The company has pivoted its strategy towards enhancing digital health offerings. The CEO is Rory Cameron, and the founder is Chris Genders, who has experience in building technology-driven healthcare solutions.


Gendius has raised GBP 0. 12 mn in its latest funding round from Nolan Capital, which values the company at GBP 20. 38 mn. To date, Gendius has completed a total of 3 deals, with the most recent deal occurring on October 5, 2020.


Gendius. co. uk develops advanced health technology solutions aimed at enhancing diabetes management. Their flagship product is a digital platform that integrates data analytics with patient monitoring tools, enabling healthcare professionals to track glucose levels, dietary habits, and medication adherence.


This platform is targeted at healthcare providers and patients in the UK and Europe, facilitating personalized treatment plans and improving patient engagement. Gendius generates revenue through subscription-based services and strategic partnerships with healthcare providers. Healthcare institutions pay for access to their digital platform, enabling patient management and monitoring. Gendius also offers its services directly to consumers, helping users manage their health through specialized tools and analytics.


In October 2020, Gendius Ltd raised GBP 0. 12 mn in venture financing led by Nolan Capital, which will be used to further develop their health technology solutions. The company is focused on expanding its product offerings, including new features for their digital platform aimed at enhancing user experience. Gendius also plans to enter additional European markets by 2025 to broaden its reach and improve health outcomes for a larger patient base.


Current Investors

Catapult Ventures Group, Crowdcube Limited, Nolan Capital

Primary Industry

Healthcare IT

Sub Industries

Healthcare IT, Web Applications, Analytics & Performance Software

Website

www.gendius.co.uk

Verticals

Mobile Apps

Company Stage

Series A

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.